CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 18, 2022 · earnings

EXEL earnings: a positive outcome, +6.7%

On February 18, 2022, Exelixis, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.7% in the window around the event. It had already run +12.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$18.34
1d before
$19.56
Event day
$19.56
1d after
$19.42
5d after

Pre-catalyst setup

+12.3%
30-day run-up
4114%
30-day volatility
0.9×
volume spike